Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d15768c3394795a562a28507ced0180 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_347c7ecab108c5cd4017338d44a2f075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8cbe999e8848ec6b5b4e92a766543623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46a53fd8b5705a1aabdc741bb7c6a460 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b40449684a6d0a2096915beac8c6aab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74d47c8ac61b60a986aff3069a2dc30c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6907 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1234 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-14 |
filingDate |
2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6509cf1fe23326c727abdb8efb17aa1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b3d062888b225a6cceddf9442da761b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45e99f3a2a1515adc264d3c69339e22c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe02e43dc219823c8a3143b8483503e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c74840488fd2c44f3ff77e432d9b707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f4ea1a9d868dd81b92564deca032177 |
publicationDate |
2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006128643-A3 |
titleOfInvention |
Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
abstract |
The invention relates to supramolecular aggregates obtained by coaggregation of two monomers: - a first monomer containing a paramagnetic or radioactive metal ion complexed by a chelating agent having a lipophilic moiety, - a second monomer containing a bioactive peptide linked to a lipophilic moiety through an organic spacer. The aggregates are selectively driven by the exposed bioactive peptide on a desired biological target. The aggregates (micelles, vesicles or liposomes) could entrap on their inner region or on their surface a pharmaceutical active principle (drug). The invention thus relates to target specific delivery of drugs and/or metal ions. The invention therefore provides compositions containing said aggregates for use as contrast agents, in nuclear medicine or MRI, for the selective delivery of drugs, and for simultaneous delivery of a drug and a metal ion. |
priorityDate |
2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |